Pegylated interferon alfa-2b as treatment of solid tumors

被引：3
|
作者：
Ronald M. Bukowski
机构：
来源：
Current Oncology Reports | 2003年 / 5卷 / 2期
关键词：
Melanoma; Renal Cell Carcinoma; Clin Oncol; Sustained Virologic Response; Maximum Tolerate Dose;
D O I：
10.1007/s11912-003-0094-7
中图分类号：
学科分类号：
摘要：
PEG-IFN á-2b is active in patients with metastatic RCC and melanoma and is tolerated well at doses up to 6.0 μg/kg/wk. This trial provides a rationale for further studies using this pegylated cytokine alone or in combination with such agents as interleukin (IL)-2.
引用
收藏
页码：87 / 88
页数：1
相关论文
共 50 条
  • [41] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients -: A randomized controlled trial
    Carrat, F
    Bani-Sadr, F
    Pol, S
    Rosenthal, E
    Lunel-Fabiani, F
    Benzekri, A
    Morand, P
    Goujard, C
    Pialoux, G
    Piroth, L
    Salmon-Céron, D
    Degott, C
    Cacoub, P
    Perronne, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23): : 2839 - 2848
  • [42] Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
    Yi-Wen Huang
    Chao-Wei Hsu
    Sheng-Nan Lu
    Ming-Lung Yu
    Chien-Wei Su
    Wei-Wen Su
    Rong-Nan Chien
    Ching-Sheng Hsu
    Shih-Jer Hsu
    Hsueh-Chou Lai
    Albert Qin
    Kuan-Chiao Tseng
    Pei-Jer Chen
    Hepatology International, 2020, 14 : 997 - 1008
  • [43] Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b
    Molloy, PJ
    Azzouz, M
    VanThiel, DH
    AMERICAN FAMILY PHYSICIAN, 1996, 54 (05) : 1598 - 1602
  • [44] Severe streptococcal cellulitis after subcutaneous pegylated interferon alfa-2B in a diabetic patient
    Lanternier, F
    Bon, C
    Memain, N
    Roulot, D
    Lortholary, O
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (12): : 1294 - 1295
  • [45] IMPROVEMENT OF ADIPOKINES IN HCV ERADICATED PATIENT TREATED WITH PEGYLATED INTERFERON ALFA-2B AND RIBAVIRIN
    Kaneko, Fumihiko
    Yokomori, Hiroaki
    Kumagai, Naoki
    Toda, Kyoko
    Tsunematsu, Satoshi
    Wakabayashi, Kanji
    Tsuchimoto, Kanji
    Saito, Hidetsugu
    Hibi, Toshifumi
    HEPATOLOGY, 2010, 52 (04) : 808A - 808A
  • [46] Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: Report of two cases
    Heidemann, J
    Ogawa, H
    Otterson, MF
    Shidham, VB
    Binion, DG
    DISEASES OF THE COLON & RECTUM, 2004, 47 (01) : 118 - 122
  • [47] LYMPHOMATOID PAPULOSIS - RESPONSE TO TREATMENT WITH RECOMBINANT INTERFERON ALFA-2B
    PROCTOR, SJ
    JACKSON, GH
    LENNARD, AL
    MARKS, J
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) : 170 - 170
  • [48] RECOMBINANT INTERFERON ALFA-2B TREATMENT OF NECROBIOTIC XANTHOGRANULOMA WITH PARAPROTEINEMIA
    VENENCIE, PY
    LEBRAS, P
    TOAN, ND
    TCHERNIA, G
    DELFRAISSY, JF
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (04) : 666 - 667
  • [49] Treatment of chronic thrombocytopenic purpura in children with interferon alfa-2b
    Torubarova, NA
    Basistova, AA
    Nikitin, DO
    Tepaev, RF
    Karelin, AF
    Kopiltzova, EA
    PEDIATRIC RESEARCH, 1999, 45 (05) : 767 - 767
  • [50] Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
    Kaymakoglu, Sabahattin
    Oguz, Dilek
    Gur, Gurden
    Gurel, Selim
    Tankurt, Ethem
    Ersoz, Galip
    Ozenirler, Seren
    Kalayci, Cem
    Poturoglu, Sule
    Cakaloglu, Yilmaz
    Okten, Atilla
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (08) : 3020 - 3022
12345